Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non–small-cell lung cancer
M Schwarz, M Alber, JV Lebesque, BJ Mijnheer… - International Journal of …, 2005 - Elsevier
Purpose: To quantify the dose escalation achievable in the treatment of non-small-cell lung
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer
M Schwarz, M Alber, JV Lebesque… - International Journal of …, 2005 - inis.iaea.org
[en] Purpose: To quantify the dose escalation achievable in the treatment of non-small-cell
lung cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
lung cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer
M Schwarz, M Alber, JV Lebesque, BJ Mijnheer… - International Journal of …, 2005 - osti.gov
Purpose: To quantify the dose escalation achievable in the treatment of non-small-cell lung
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
M Schwarz, M Alber, JV Lebesque… - … Journal of Radiation …, 2005 - europepmc.org
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the
dose in the treatment of non-small-cell lung cancer. - Abstract - Europe PMC Sign in | Create an …
dose in the treatment of non-small-cell lung cancer. - Abstract - Europe PMC Sign in | Create an …
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer
M Schwarz, M Alber, JV Lebesque… - … journal of radiation …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose To quantify the dose escalation achievable in the treatment of non-small-cell lung
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non–small-cell lung cancer
M Schwarz, M Alber, JV Lebesque, BJ Mijnheer… - International Journal of …, 2005 - infona.pl
Purpose: To quantify the dose escalation achievable in the treatment of non-small-cell lung
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non–small-cell lung cancer
M Schwarz, M Alber, JV Lebesque… - International Journal of …, 2005 - redjournal.org
Purpose: To quantify the dose escalation achievable in the treatment of non-small-cell lung
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …
cancer (NSCLC) by allowing dose heterogeneity in the target volume or using intensity …